Stocks and Investing Stocks and Investing
Fri, May 27, 2022
Thu, May 26, 2022
Wed, May 25, 2022

Leland Gershell Initiated (TRVI) at Buy and Held Target at $10 on, May 25th, 2022


Published on 2024-10-27 21:17:17 - WOPRAI, Leland Gershell
  Print publication without navigation


Leland Gershell of Oppenheimer, Initiated "Trevi Therapeutics, Inc." (TRVI) at Buy and Held Target at $10 on, May 25th, 2022.

Leland has made no other calls on TRVI in the last 4 months.



There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Leland's Rating of Hold.



This is the rating of the analyst that currently disagrees with Leland


  • Nathan Weinstein of "Aegis Capital" Initiated at Strong Buy and Held Target at $10 on, Tuesday, March 29th, 2022